Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5% (Q78237270)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

title

Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5% (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

I Arany

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

S K Tyring

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M A Stanley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M A Tomai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

R L Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

M H Smith

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

D J McDermott

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

H B Slade

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

page(s)

55-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway

12 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Status of local cellular immunity in interferon-responsive and -nonresponsive human papillomavirus-associated lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Effect of interferon therapy on human papillomavirus copy number in patients with Condyloma acuminatum

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Epidemiology of genital human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Management of Genital Infection Caused by Human Papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Direct sequencing of consensus primer generated PCR fragments of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Cytokine induction in mice by the immunomodulator imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Imiquimod 5% cream (Aldara).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Human papillomavirus infection and genital warts: update on epidemiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Cytokine induction by the immunomodulators imiquimod and S-27609

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900033-9

7 January 2021

10.1016/S0166-3542(99)00033-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json

12 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10480263%20AND%20SRC:MED&resulttype=core&format=json